Suchergebnisse - "Meroni, Pier Luigi"

PubPharm (23)

1

Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases : A Multicentre, Nationwide Study on 299 Randomly Selected Individuals

enthalten in: Clinical reviews in allergy & immunology | 2022

von Andreoli, L. | Nalli, C. | Lazzaroni, M. | +60

2

Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases

enthalten in: Journal of autoimmunity | 2020

von Marziale, A. | Bettacchioli, E. | Picart, G. | +7

3

Personalized medicine in rheumatoid arthritis : How immunogenicity impacts use of TNF inhibitors

enthalten in: Autoimmunity reviews | 2020

von Bodio, C. | Grossi, C. | Pregnolato, F. | +16

4

A WHO Reference Reagent for lupus (anti-dsDNA) antibodies : international collaborative study to evaluate a candidate preparation

enthalten in: Annals of the rheumatic diseases | 2019

von Fox, B. | Hockley, J. | Rigsby, P. | +3

5

"Disease knowledge index" and perspectives on reproductive issues : A nationwide study on 398 women with autoimmune rheumatic diseases

enthalten in: Joint bone spine | 2019

von Andreoli, L. | Lazzaroni, M. | Carini, C. | +60

6

Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers : A Multicenter Study on 62 Pregnancies

enthalten in: Frontiers in immunology | 2019

von Lazzaroni, M. | Fredi, M. | Andreoli, L. | +13

7

Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis : 52-Week Results from the CZP-SPEED Study

enthalten in: Advances in therapy | 2018

von Sarzi-Puttini, P. | Filippucci, E. | Adami, S. | +7

8

Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis : Clinical and Laboratory Correlates of Remission Duration

enthalten in: Arthritis care & research | 2018

von Simonini, G. | Ferrara, G. | Pontikaki, I. | +5

9

The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts : implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study: GIRRCS=Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale

enthalten in: Medicine | 2018

von Fasano, S. | Margiotta, D. | Gualtierotti, R. | +10

10

Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study

enthalten in: Journal of autoimmunity | 2018

von Iaccarino, L. | Andreoli, L. | Bocci, E. | +25